RICHARDSON , Texas (Nov. 14, 2005) – Dr. Steven R. Goodman, who holds a chaired professorship and directs a research institute at The University of Texas at Dallas (UTD), was named editor-in-chief of Experimental Biology and Medicine, a leading journal in the biomedical research field.
Goodman will begin a three-year term, which is renewable for an additional three years, at the journal on July 1, 2006. He will continue in his current roles at UTD, where he is the C.L. and Amelia A. Lundell Professor of Life Sciences and director of the Institute of Biomedical Sciences and Technology (IBMST).
“I am honored to be selected editor-in-chief of Experimental Biology and Medicine, a journal that recently celebrated its centennial anniversary and is a world leader in the publication of biomedical research,” said Goodman. “During my tenure, I hope to expand the journal’s focus in the areas of interdisciplinary team research, as well as translational research, which is the transfer of findings from the laboratory to clinical applications and commercial products.”
“The entire UTD community is proud that Steve Goodman has been chosen to serve in this important capacity,” said university President Dr. David E. Daniel. “An editor-in-chief possesses a tremendous love for his or her discipline, a strong work ethic and deep dedication to serving the profession. It is one of the highest recognitions and expressions of trust that a scholar can receive from his or her peers. Dr. Goodman’s recognition is well deserved.”
The peer-reviewed journal is published 11 times a year by the Society for Experimental Biology and Medicine, a not-for-profit scientific society founded in 1903 to promote investigation in the biomedical sciences by encouraging and facilitating interchange of scientific information among disciplines. The organization is based in Maywood, New Jersey.
Goodman joined UTD in 2001 to found the university’s Sickle Cell Disease Research Center. Eighteen months later, he established IBMST to provide added focus and effort to the university’s research and education initiatives in areas related to combating disease and improving health. The institute has created interdisciplinary teams of faculty members and researchers from UTD and other universities from such disparate fields as physics, chemistry, mathematics, computer science, engineering, nanotechnology and the biological sciences. The teams’ efforts are focused in four broad areas of research – diseases of the aging brain, blood disorders, molecular diagnostics and biomedical technology and bioengineering, security and defense.
Goodman earned a doctorate in biochemistry from St. Louis University Medical School and a bachelor of science degree in chemistry from the State University of New York at Stony Brook. He did post-doctoral research in cell biology at Harvard University and molecular biology at Harvard Medical School.
Goodman is the current president of the Association of Anatomy, Cell Biology and Neurobiology Chairs, a national biomedical sciences organization. He is also a professor of molecular and cell biology at UTD and an adjunct professor of cell biology at The University of Texas Southwestern Medical Center at Dallas.
The University of Texas at Dallas, located at the convergence of Richardson, Plano and Dallas in the heart of the complex of major multinational technology corporations known as the Telecom Corridor®, enrolls nearly 14,500 students. The school’s freshman class traditionally stands at the forefront of Texas state universities in terms of average SAT scores. The university offers a broad assortment of bachelor’s, master’s and doctoral degree programs. For additional information about UTD, please visit the university’s website at www.utdallas.edu.